COVID-19 outbreak had drastically modified the treatment of chronic inflammatory diseases (i.e. psoriasis) in terms of drug delivery, visits booking and patients' adherence. Furthermore, during lockdown several patients modified or even discontinued their anti-psoriatic treatments due to misinformation, COVID-phobia or even cabin fever syndrome experiencing a psoriatic flare and decreasing the overall daily functionality and quality of life.
COVID‐19 vaccination and psoriatic patients under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers / G. Damiani, F. Allocco, P. o Malagoli. - In: CLINICAL AND EXPERIMENTAL DERMATOLOGY. - ISSN 0307-6938. - (2021). [Epub ahead of print] [10.1111/ced.14631]
COVID‐19 vaccination and psoriatic patients under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers
G. Damiani
Primo
Conceptualization
;
2021
Abstract
COVID-19 outbreak had drastically modified the treatment of chronic inflammatory diseases (i.e. psoriasis) in terms of drug delivery, visits booking and patients' adherence. Furthermore, during lockdown several patients modified or even discontinued their anti-psoriatic treatments due to misinformation, COVID-phobia or even cabin fever syndrome experiencing a psoriatic flare and decreasing the overall daily functionality and quality of life.File | Dimensione | Formato | |
---|---|---|---|
ced.14631.pdf
Open Access dal 06/03/2022
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
4.31 MB
Formato
Adobe PDF
|
4.31 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.